RXST | tickerfilter.com

Fundamental analysis

19%

Profitability 0%

Dept financing 5%

Liquidity 65%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

4.36%

1 Month

-16.10%

3 Months

-32.87%

6 Months

-53.47%

1 Year

-45.24%

2 Year

72.84%

Key data

Stock price

$25.84

P/E Ratio

0.00

DAY RANGE

$25.11 - $25.96

EPS

-$0.55

52 WEEK RANGE

$24.64 - $66.54

52 WEEK CHANGE

-$44.74

MARKET CAP

1.386 B

YIELD

N/A

SHARES OUTSTANDING

37.196 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.28

PUBLIC FLOAT

AVERAGE 10 VOLUME

$591,194

AVERAGE 30 VOLUME

$612,807

Company detail

CEO: Ronald M. Kurtz
Region: US
Website: rxsight.com
Employees: 220
IPO year: 2021

Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

RxSight, Inc. engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. The company was formerly known as Calhoun Vision, Inc.

RXST - RxSight Inc